Affinity Asset Advisors’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Hold
0
51
2022
Q2
Hold
0
48